Annual FCF
-$68.47 M
-$24.85 M-56.95%
December 31, 2023
Summary
- As of February 23, 2025, ATXS annual free cash flow is -$68.47 million, with the most recent change of -$24.85 million (-56.95%) on December 31, 2023.
- During the last 3 years, ATXS annual FCF has fallen by -$35.95 million (-110.56%).
- ATXS annual FCF is now -317.27% below its all-time high of -$16.41 million, reached on December 31, 2013.
Performance
ATXS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$27.98 M
-$10.89 M-63.69%
September 30, 2024
Summary
- As of February 23, 2025, ATXS quarterly free cash flow is -$27.98 million, with the most recent change of -$10.89 million (-63.69%) on September 30, 2024.
- Over the past year, ATXS quarterly FCF has dropped by -$13.72 million (-96.22%).
- ATXS quarterly FCF is now -506.13% below its all-time high of -$4.62 million, reached on March 31, 2014.
Performance
ATXS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$94.43 M
-$13.72 M-17.00%
September 30, 2024
Summary
- As of February 23, 2025, ATXS TTM free cash flow is -$94.43 million, with the most recent change of -$13.72 million (-17.00%) on September 30, 2024.
- Over the past year, ATXS TTM FCF has dropped by -$45.52 million (-93.06%).
- ATXS TTM FCF is now -1945.25% below its all-time high of -$4.62 million, reached on March 31, 2014.
Performance
ATXS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ATXS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -57.0% | -96.2% | -93.1% |
| 3 y3 years | -110.6% | -96.2% | -93.1% |
| 5 y5 years | -191.8% | -96.2% | -93.1% |
ATXS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -126.9% | at low | -345.2% | +7.5% | -213.0% | at low |
| 5 y | 5-year | -157.6% | at low | -345.2% | +7.5% | -255.4% | at low |
| alltime | all time | -317.3% | at low | -506.1% | +7.5% | -1945.3% | at low |
Astria Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$27.98 M(+63.7%) | -$94.43 M(+17.0%) |
| Jun 2024 | - | -$17.10 M(-10.5%) | -$80.71 M(+8.6%) |
| Mar 2024 | - | -$19.09 M(-36.9%) | -$74.31 M(+8.5%) |
| Dec 2023 | -$68.47 M(+57.0%) | -$30.25 M(+112.1%) | -$68.47 M(+40.0%) |
| Sep 2023 | - | -$14.26 M(+33.3%) | -$48.91 M(+8.8%) |
| Jun 2023 | - | -$10.70 M(-19.3%) | -$44.96 M(+1.4%) |
| Mar 2023 | - | -$13.26 M(+24.0%) | -$44.32 M(+1.6%) |
| Dec 2022 | -$43.62 M(+44.6%) | -$10.70 M(+3.8%) | -$43.62 M(+11.2%) |
| Sep 2022 | - | -$10.31 M(+2.4%) | -$39.22 M(+7.0%) |
| Jun 2022 | - | -$10.06 M(-19.9%) | -$36.66 M(+7.8%) |
| Mar 2022 | - | -$12.56 M(+99.8%) | -$33.99 M(+12.7%) |
| Dec 2021 | -$30.17 M(-7.2%) | -$6.29 M(-18.9%) | -$30.17 M(-5.6%) |
| Sep 2021 | - | -$7.75 M(+4.7%) | -$31.96 M(-6.5%) |
| Jun 2021 | - | -$7.40 M(-15.3%) | -$34.18 M(-0.3%) |
| Mar 2021 | - | -$8.74 M(+8.3%) | -$34.27 M(+5.4%) |
| Dec 2020 | -$32.52 M(+22.3%) | -$8.07 M(-19.0%) | -$32.52 M(+0.9%) |
| Sep 2020 | - | -$9.97 M(+33.1%) | -$32.22 M(+12.2%) |
| Jun 2020 | - | -$7.49 M(+7.2%) | -$28.72 M(+6.5%) |
| Mar 2020 | - | -$6.99 M(-10.1%) | -$26.97 M(+1.5%) |
| Dec 2019 | -$26.58 M | -$7.77 M(+20.0%) | -$26.57 M(+10.4%) |
| Sep 2019 | - | -$6.47 M(+12.8%) | -$24.07 M(+3.0%) |
| Jun 2019 | - | -$5.74 M(-12.9%) | -$23.37 M(+0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$6.59 M(+25.0%) | -$23.23 M(-1.0%) |
| Dec 2018 | -$23.46 M(-12.7%) | -$5.27 M(-8.8%) | -$23.46 M(-1.5%) |
| Sep 2018 | - | -$5.78 M(+3.1%) | -$23.83 M(-6.5%) |
| Jun 2018 | - | -$5.60 M(-17.8%) | -$25.49 M(-0.4%) |
| Mar 2018 | - | -$6.82 M(+21.0%) | -$25.60 M(-4.8%) |
| Dec 2017 | -$26.89 M(-19.3%) | -$5.64 M(-24.2%) | -$26.89 M(-8.1%) |
| Sep 2017 | - | -$7.43 M(+30.2%) | -$29.26 M(+1.7%) |
| Jun 2017 | - | -$5.71 M(-29.6%) | -$28.78 M(-10.1%) |
| Mar 2017 | - | -$8.11 M(+1.3%) | -$31.99 M(-4.0%) |
| Dec 2016 | -$33.32 M(+10.3%) | -$8.01 M(+15.3%) | -$33.32 M(-3.2%) |
| Sep 2016 | - | -$6.95 M(-22.2%) | -$34.41 M(-2.6%) |
| Jun 2016 | - | -$8.93 M(-5.4%) | -$35.32 M(+9.0%) |
| Mar 2016 | - | -$9.44 M(+3.7%) | -$32.40 M(+7.2%) |
| Dec 2015 | -$30.21 M(+46.4%) | -$9.10 M(+15.9%) | -$30.21 M(+11.5%) |
| Sep 2015 | - | -$7.85 M(+30.8%) | -$27.10 M(+13.0%) |
| Jun 2015 | - | -$6.00 M(-17.2%) | -$23.98 M(+3.0%) |
| Mar 2015 | - | -$7.25 M(+21.1%) | -$23.28 M(+12.8%) |
| Dec 2014 | -$20.64 M(+25.8%) | -$5.99 M(+26.6%) | -$20.64 M(+40.9%) |
| Sep 2014 | - | -$4.73 M(-10.8%) | -$14.65 M(+47.7%) |
| Jun 2014 | - | -$5.30 M(+14.9%) | -$9.92 M(+114.9%) |
| Mar 2014 | - | -$4.62 M | -$4.62 M |
| Dec 2013 | -$16.41 M | - | - |
FAQ
- What is Astria Therapeutics annual free cash flow?
- What is the all time high annual FCF for Astria Therapeutics?
- What is Astria Therapeutics annual FCF year-on-year change?
- What is Astria Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Astria Therapeutics?
- What is Astria Therapeutics quarterly FCF year-on-year change?
- What is Astria Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Astria Therapeutics?
- What is Astria Therapeutics TTM FCF year-on-year change?
What is Astria Therapeutics annual free cash flow?
The current annual FCF of ATXS is -$68.47 M
What is the all time high annual FCF for Astria Therapeutics?
Astria Therapeutics all-time high annual free cash flow is -$16.41 M
What is Astria Therapeutics annual FCF year-on-year change?
Over the past year, ATXS annual free cash flow has changed by -$24.85 M (-56.95%)
What is Astria Therapeutics quarterly free cash flow?
The current quarterly FCF of ATXS is -$27.98 M
What is the all time high quarterly FCF for Astria Therapeutics?
Astria Therapeutics all-time high quarterly free cash flow is -$4.62 M
What is Astria Therapeutics quarterly FCF year-on-year change?
Over the past year, ATXS quarterly free cash flow has changed by -$13.72 M (-96.22%)
What is Astria Therapeutics TTM free cash flow?
The current TTM FCF of ATXS is -$94.43 M
What is the all time high TTM FCF for Astria Therapeutics?
Astria Therapeutics all-time high TTM free cash flow is -$4.62 M
What is Astria Therapeutics TTM FCF year-on-year change?
Over the past year, ATXS TTM free cash flow has changed by -$45.52 M (-93.06%)